Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (201-210 of 348) with videos related to

Pageof 35
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 30, 2010
A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancerJoseph Treat, Martin J Edelman, Chandra P Belani, et al.
Heart, Lung & Circulation|July 18, 2016
Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive CasesJ J Edelman, N Okiwelu, K Anvardeen, et al.
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
Forensic Science International|February 22, 2002
16 X-chromosome STR loci frequency data from a German populationJ Edelman, S Hering, M Michael, et al.
Science Robotics|October 29, 2019
Noninvasive neuroimaging enhances continuous neural tracking for robotic device controlB J Edelman, J Meng, D Suma, et al.
Clinical Lung Cancer|October 16, 2012
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung CancerDavid R Spigel, Martin J Edelman, Tony Mok, et al.
Cancer|December 24, 2003
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinomaPrimo N Lara, Frederick J Meyers, Lisa Y Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Cancer|April 10, 2004
Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urotheliumRobert Dreicer, Judith Manola, Bruce J Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trialsPrimo N Lara, Mary W Redman, Karen Kelly, et al.
Pageof 35

Showing results (201-210 of 348) with videos related to

Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|March 30, 2010
A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancerJoseph Treat, Martin J Edelman, Chandra P Belani, et al.
Heart, Lung & Circulation|July 18, 2016
Surgical Pulmonary Embolectomy: Experience in a Series of 37 Consecutive CasesJ J Edelman, N Okiwelu, K Anvardeen, et al.
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
Forensic Science International|February 22, 2002
16 X-chromosome STR loci frequency data from a German populationJ Edelman, S Hering, M Michael, et al.
Science Robotics|October 29, 2019
Noninvasive neuroimaging enhances continuous neural tracking for robotic device controlB J Edelman, J Meng, D Suma, et al.
Clinical Lung Cancer|October 16, 2012
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung CancerDavid R Spigel, Martin J Edelman, Tony Mok, et al.
Cancer|December 24, 2003
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinomaPrimo N Lara, Frederick J Meyers, Lisa Y Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancerCharles M Rudin, Mark Kozloff, Philip C Hoffman, et al.
Cancer|April 10, 2004
Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urotheliumRobert Dreicer, Judith Manola, Bruce J Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trialsPrimo N Lara, Mary W Redman, Karen Kelly, et al.
Pageof 35